IMM 1.72% 29.5¢ immutep limited

Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial, page-2

  1. 364 Posts.
    lightbulb Created with Sketch. 135
    Announcements just keep coming all with great data. Another cracker 67% of patients having near-complete responses!
    https://hotcopper.com.au/data/attachments/6141/6141009-3ee66de07ed8f68fcd9c07b3b2224e65.jpg
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.